Candida auris outbreak: Superbug fungus has sickened hundreds, CDC says

Candida auris outbreak: Superbug fungus has sickened hundreds, CDC says

Candida auris outbreak: Superbug fungus has sickened hundreds, CDC says

According to the CDC Most of the confirmed C. Auris cases in the USA have been discovered in NY and New Jersey.

India, Pakistan, China, Japan, Russia, Australia, US, Canada, Britain, France, Germany, Spain, South Africa, Kenya and list goes on with at least 587 cases reported from US alone, 309 cases in NY, 104 in New Jersey and 144 in IL, according to the CDC.

According to a 2017 report, most cases were spread in hospitals or between family members. But with drug-resistant fungi and bacteria, their genes evolve so quickly that the treatment meant to target them proves ineffective and allows the unsafe disease to spread.

The strain of Candida auris cultured in a petri dish. In the 10 years since its debut, the fungus has spread rapidly around the globe and has now been positively identified throughout Asia, Africa, the Americas, and Europe. Some 41% of the Spanish hospital patients affected died within 30 days of being diagnosed. "More than 1 in 3 patients with invasive C. auris infection (for example, an infection that affects the blood, heart, or brain) die".

"Cases in New York are primarily concentrated among hospital patients and nursing home residents in New York City", the state's health department said. Resistant germs called "superbugs" have been known to be most deadly to people with weak immune systems such as newborns, elderly, smokers, diabetics and people with autoimmune disorders who utilize steroids that limit their body's defenses.

The fungus, which can be hard to detect, was discovered in 2009 in Japan. The fungus can cause different types of infection, including wound infection, bloodstream infection, and ear infection.

The Council of State and Territorial Epidemiologists (CSTE) says Candida auris infections have been "associated with up to 40% in-hospital mortality".

A map of Candida auris cases around the world.

Further, in the same study linked above, 98% of the clinical-case patients were resistant to fluconazole, which is used to treat serious fungal infections such as meningitis.

Researchers are searching for answers as to how C. auris developed a resistance to anti-fungal medications.

"PHE is working closely with the NHS to provide expert support and advice on infection control measures to limit the spread of Candida auris". She called the fungus "worrisome" because it's drug resistant.

As of March 18, the Department of Health for NY said it had recorded 309 cases of the disease where the patient fell ill while it found an additional 429 cases where people carried the disease on their body but weren't infected. On Tuesday, April 25, 2017, NY state health officials provided new details about a continuing outbreak of the infection.

Related news